Zhao Hong-Liang, Xue Chong, Xiong Xiang-Hua, Zhang Wei, Zhu Hou-Chu, Liu Zhi-Min
Beijing Institute of Biotechnology, Beijing 100071, China.
Sheng Wu Gong Cheng Xue Bao. 2004 May;20(3):394-7.
AX15 is a mutein of naturally occurring human ciliary neurophic factor (hCNTF), with improved biological activity, stability and solubility. AX15 is susceptible to protease degradation when expressed in Pichia pastoris. Amino acid sequencing revealed the degradation was occurred behind position 12 and 13 amino acid residues, which constitute a dibasic site, RR. Based on the substrate specificity of KEX2, a KEX2 resistant mutein of AX15-AX15 (R13K) was constructed, in which RR was replaced by RK. It was demonstrated that the stability of AX15 (R13K) improved significantly, as no degradation was detected even after 120 hours of induction. AX15 (R13K) was purified to homogeneity by ultrafiltration and gel filtration. TF-1 cell survival bioassay showed AX15 (R13K) had equivalent specific activity to AX15. The protease resistant mutein of AX15 may have greater in vivo stability and thus have superior therapeutic potential.
AX15是天然存在的人睫状神经营养因子(hCNTF)的一种突变体,具有改善的生物活性、稳定性和溶解性。AX15在毕赤酵母中表达时易受蛋白酶降解。氨基酸测序显示降解发生在构成双碱性位点RR的第12和13个氨基酸残基之后。基于KEX2的底物特异性,构建了AX15的KEX2抗性突变体AX15(R13K),其中RR被RK取代。结果表明,AX15(R13K)的稳定性显著提高,即使在诱导120小时后也未检测到降解。通过超滤和凝胶过滤将AX15(R13K)纯化至同质。TF-1细胞存活生物测定表明AX15(R13K)具有与AX15相当的比活性。AX15的蛋白酶抗性突变体可能在体内具有更高的稳定性,因此具有更好的治疗潜力。